Corrigendum: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors (Annals of Oncology (2018) DOI: 10.1093/annonc/mdy216)

M. Diossy; L. Reiniger; Z. Sztupinszki; M. Krzystanek; K. M. Timms; C. Neff; C. Solimeno; D. Pruss; A. C. Eklund; E. Tóth; O. Kiss; O. Rusz; G. Cserni; T. Zombori; B. Székely; J. Kulka; J. Tímár; I. Csabai; Z. Szallasi

ArticleOPEN ACCESS

Corrigendum: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors (Annals of Oncology (2018) DOI: 10.1093/annonc/mdy216)

Diossy M
Reiniger L
Sztupinszki Z
et al.

Annals of Oncology

DOI: 10.1093/annonc/mdz081

2Citations

24Readers

Abstract

Author Janina Kulka was originally missed from the author listing. She has now been added.

Cite

CITATION STYLE

APA

Diossy, M., Reiniger, L., Sztupinszki, Z., Krzystanek, M., Timms, K. M., Neff, C., … Szallasi, Z. (2019, August 1). Corrigendum: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors (Annals of Oncology (2018) DOI: 10.1093/annonc/mdy216). Annals of Oncology. Oxford University Press. https://doi.org/10.1093/annonc/mdz081

Corrigendum: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors (Annals of Oncology (2018) DOI: 10.1093/annonc/mdy216)

Abstract

Cite

Register to see more suggestions